Literature DB >> 19299707

PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.

Julie Zikherman1, Michelle Hermiston, David Steiner, Kiminori Hasegawa, Andrew Chan, Arthur Weiss.   

Abstract

Pep and CD45 are tyrosine phosphatases whose targets include the Src-family kinases, critical mediators of Ag receptor signaling. A polymorphism in PTPN22, the gene that encodes the human Pep orthologue Lyp, confers susceptibility to multiple human autoimmune diseases in the context of complex genetic backgrounds. However, the functional significance of the R620W risk allele is not clear. We report that misexpression of wild-type or R620W Pep/Lyp in Jurkat cells, in the context of its binding partner Csk, unmasks the risk allele as a hypomorph. It has been shown previously that although Pep-deficient mice on the B6 background have hyperresponsive memory T cells, autoimmunity does not develop. Mice containing a point mutation in the CD45 juxtamembrane wedge domain (E613R) develop a B cell-driven, lupus-like disease on the mixed 129/B6 background, but not on the B6 background. We studied the ability of Pep deficiency to act as a genetic modifier of the CD45 E613R mutation on the nonautoimmune B6 background to understand how complex susceptibility loci might interact in autoimmunity. In this study we report that double mutant mice develop a lupus-like disease as well as lymphadenopathy, polyclonal lymphocyte activation, and accelerated memory T cell formation. Following Ag receptor stimulation, peripheral B cells in the double mutant mice phenocopy hyperresponsive CD45 E613R B cells, whereas peripheral T cells respond like Pep(-/-) T cells. These studies suggest that Pep(-/-) T cells in the context of a susceptible microenvironment can drive hyperresponsive CD45 E613R B cells to break tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299707      PMCID: PMC2765978          DOI: 10.4049/jimmunol.0803317

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins.

Authors:  A J MacGregor; H Snieder; A S Rigby; M Koskenvuo; J Kaprio; K Aho; A J Silman
Journal:  Arthritis Rheum       Date:  2000-01

2.  Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family.

Authors:  Q Lu; G Lemke
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

Review 3.  CD45: a critical regulator of signaling thresholds in immune cells.

Authors:  Michelle L Hermiston; Zheng Xu; Arthur Weiss
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

4.  Features of systemic lupus erythematosus in Dnase1-deficient mice.

Authors:  M Napirei; H Karsunky; B Zevnik; H Stephan; H G Mannherz; T Möröy
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

5.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.

Authors:  M Kawabuchi; Y Satomi; T Takao; Y Shimonishi; S Nada; K Nagai; A Tarakhovsky; M Okada
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

6.  Projection of an immunological self shadow within the thymus by the aire protein.

Authors:  Mark S Anderson; Emily S Venanzi; Ludger Klein; Zhibin Chen; Stuart P Berzins; Shannon J Turley; Harald von Boehmer; Roderick Bronson; Andrée Dierich; Christophe Benoist; Diane Mathis
Journal:  Science       Date:  2002-10-10       Impact factor: 47.728

7.  Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains.

Authors:  L Morel; B P Croker; K R Blenman; C Mohan; G Huang; G Gilkeson; E K Wakeland
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

8.  B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.

Authors:  S N Liossis; B Kovacs; G Dennis; G M Kammer; G C Tsokos
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

9.  An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity.

Authors:  R Majeti; Z Xu; T G Parslow; J L Olson; D I Daikh; N Killeen; A Weiss
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

10.  Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.

Authors:  T Brdicka; D Pavlistová; A Leo; E Bruyns; V Korínek; P Angelisová; J Scherer; A Shevchenko; I Hilgert; J Cerný; K Drbal; Y Kuramitsu; B Kornacker; V Horejsí; B Schraven
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  78 in total

Review 1.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

2.  microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells.

Authors:  Erik Allen Lykken; Qi-Jing Li
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 3.  Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22.

Authors:  Karen Cerosaletti; Jane H Buckner
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Cutting edge: An in vivo reporter reveals active B cell receptor signaling in the germinal center.

Authors:  James Mueller; Mehrdad Matloubian; Julie Zikherman
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

Review 5.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

6.  PTPN22 alters the development of regulatory T cells in the thymus.

Authors:  Christian J Maine; Emma E Hamilton-Williams; Jocelyn Cheung; Stephanie M Stanford; Nunzio Bottini; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

7.  Unbiased modifier screen reveals that signal strength determines the regulatory role murine TLR9 plays in autoantibody production.

Authors:  Robyn E Mills; Viola C Lam; Allison Tan; Nicole Cresalia; Nir Oksenberg; Julie Zikherman; Mark Anderson; Arthur Weiss; Michelle L Hermiston
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

Review 8.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 9.  A functional framework for interpretation of genetic associations in T1D.

Authors:  Gerald T Nepom; Jane H Buckner
Journal:  Curr Opin Immunol       Date:  2012-07-26       Impact factor: 7.486

10.  The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.

Authors:  J F Mendoza Rincón; D López Cano; S Jiménez Morales; M L Rivas Jiménez; R E Barbosa Cobos; J Ramírez Bello
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.